
Keywords: پروتئین واکنشی سی; IR; insulin resistance; MS; metabolic syndrome; DM2; diabetes mellitus type 2; CVD; cardiovascular disease; CHD; coronary heart disease; CVI; cerebrovascular infarction; HOMA-IR; homeostatic model assessment for insulin resistance; ATP III; Adult Treatmen